Compare $KYNB vs $MCRB | Chartloom

Compare

$KYNB vs $MCRB

Kyntra Bio Inc · Seres Therapeutics Inc

KYNB

Kyntra Bio Inc

MCRB

Seres Therapeutics Inc

Compare $KYNB vs $MCRB

Comparing Kyntra Bio Inc and Seres Therapeutics Inc

KYNBKyntra Bio Inc

MCRBSeres Therapeutics Inc

KYNBKyntra Bio Inc

Market cap

$25M

P/E (TTM)

0.14x

Forward P/E (NTM)

—

Forward P/S (NTM)

3.52x

Rev growth (TTM)

-91.4%

YTD performance

-33.3%

52W performance

-46.4%

FCF yield

-153.8%

MCRBSeres Therapeutics Inc

Market cap

$26M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-82.1%

52W performance

-86.2%

FCF yield

-195.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

KYNB

MCRB

Detailed metrics comparison

KYNB

Kyntra Bio Inc

MCRB

Seres Therapeutics Inc

Market Cap

KYNB$25M

MCRB$26M

Enterprise Value

KYNB$-26M

MCRB$11M

Price

KYNB$6.11

MCRB$2.71

P/E Ratio

KYNB0.14x

MCRBN/A

P/S Ratio

KYNB5.36x

MCRB13.93x

EV/Sales

KYNB-5.61x

MCRB5.65x

EV/EBITDA

KYNB0.00x

MCRB0.00x

P/B Ratio

KYNB0.97x

MCRB0.85x

P/FCF Ratio

KYNBN/A

MCRBN/A

EV/FCF

KYNB0.68x

MCRB-0.21x

PEG Ratio

KYNBN/A

MCRBN/A

Forward P/E (NTM)

KYNBN/A

MCRBN/A

Forward P/S (NTM)

KYNB3.52x

MCRBN/A

Revenue (TTM)

KYNB$5M

MCRB$2M

Revenue Growth (YoY)

KYNB-91.4%

MCRBN/A

Forward Rev Growth

KYNB21.6%

MCRB-98.0%

Gross Margin (TTM)

KYNB6.3%

MCRB0.0%

Operating Margin (TTM)

KYNB0.0%

MCRB0.0%

EBITDA Margin (TTM)

KYNB-1083.7%

MCRB-3971.2%

Net Margin (TTM)

KYNB3967.8%

MCRB-1192.9%

FCF Margin (TTM)

KYNB-824.4%

MCRB-2724.1%

Net Income (TTM)

KYNB$183M

MCRB$-22M

FCF (TTM)

KYNB$-38M

MCRB$-51M

EPS (TTM)

KYNB$45.25

MCRB-$2.30

ROE (TTM)

KYNB-29091.0%

MCRB-6032.0%

ROA (TTM)

KYNB156.8%

MCRB-1794.0%

ROIC (TTM)

KYNB-25645.0%

MCRB-6032.0%

Cash

KYNB$51M

MCRB$16M

Debt

KYNB$0

MCRB$0

Net Cash/Debt

KYNB$51M

MCRB$16M

Current Ratio (TTM)

KYNB2.69x

MCRB2.11x

Quick Ratio (TTM)

KYNB2.57x

MCRB2.04x

Debt/Equity (TTM)

KYNB0.59x

MCRB0.00x

Debt/Assets (TTM)

KYNB0.0%

MCRB0.0%

Interest Coverage (TTM)

KYNBN/A

MCRBN/A

Net Debt/EBITDA (TTM)

KYNB0.00x

MCRB0.00x

Beta

KYNB1.07

MCRB0.49

52W Performance

KYNB-46.4%

MCRB-86.2%

YTD Performance

KYNB-33.3%

MCRB-82.1%

% from 52W High

KYNB-47.6%

MCRB-91.0%

% from 52W Low

KYNB8.7%

MCRB12.0%

Asset Turnover (TTM)

KYNB0.05x

MCRB0.02x

FCF Yield (TTM)

KYNB-153.8%

MCRB-195.5%

Earnings Yield (TTM)

KYNB740.3%

MCRB-85.6%

Dividend Yield (TTM)

KYNBN/A

MCRBN/A

Rule of 40

KYNB-915.8

MCRB-2,724.1

EV/GP/RG

KYNBN/A

MCRBN/A

Ticker research

View KYNB research View MCRB research

Metric	KYNB Kyntra Bio Inc	MCRB Seres Therapeutics Inc
Market & Valuation
Market Cap	$25M	$26M
Enterprise Value	$-26M	$11M
Price	$6.11	$2.71
P/E Ratio	0.14x	N/A
P/S Ratio	5.36x	13.93x
EV/Sales	-5.61x	5.65x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.97x	0.85x
P/FCF Ratio	N/A	N/A
EV/FCF	0.68x	-0.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.52x	N/A
Revenue & Growth
Revenue (TTM)	$5M	$2M
Revenue Growth (YoY)	-91.4%	N/A
Forward Rev Growth	21.6%	-98.0%
Profitability
Gross Margin (TTM)	6.3%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1083.7%	-3971.2%
Net Margin (TTM)	3967.8%	-1192.9%
FCF Margin (TTM)	-824.4%	-2724.1%
Net Income (TTM)	$183M	$-22M
FCF (TTM)	$-38M	$-51M
EPS (TTM)	$45.25	-$2.30
ROE (TTM)	-29091.0%	-6032.0%
ROA (TTM)	156.8%	-1794.0%
ROIC (TTM)	-25645.0%	-6032.0%
Financial Health
Cash	$51M	$16M
Debt	$0	$0
Net Cash/Debt	$51M	$16M
Current Ratio (TTM)	2.69x	2.11x
Quick Ratio (TTM)	2.57x	2.04x
Debt/Equity (TTM)	0.59x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.07	0.49
52W Performance	-46.4%	-86.2%
YTD Performance	-33.3%	-82.1%
% from 52W High	-47.6%	-91.0%
% from 52W Low	8.7%	12.0%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.02x
FCF Yield (TTM)	-153.8%	-195.5%
Earnings Yield (TTM)	740.3%	-85.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-915.8	-2,724.1
EV/GP/RG	N/A	N/A
Ticker research	View KYNB research	View MCRB research

Valuation

P/E Ratio

KYNB

0.14x

P/S Ratio

KYNB

5.36x

MCRB

13.93x

EV/FCF

MCRB

-0.21x

KYNB

0.68x

Growth & revenue

Revenue Growth TTM

KYNB

-91.4%

Forward Revenue Growth

KYNB

21.6%

MCRB

-98.0%

Profitability & performance

Gross Margin

KYNB

6.3%

MCRB

0.0%

ROE

MCRB

-6032.0%

KYNB

-29091.0%

FCF Yield %

KYNB

-153.8%

MCRB

-195.5%

52-Week Performance

KYNB

-46.4%

MCRB

-86.2%

Detailed metrics comparison

KYNB

Kyntra Bio Inc

MCRB

Seres Therapeutics Inc

Market Cap

KYNB$25M

MCRB$26M

Enterprise Value

KYNB$-26M

MCRB$11M

Price

KYNB$6.11

MCRB$2.71

P/E Ratio

KYNB0.14x

MCRBN/A

P/S Ratio

KYNB5.36x

MCRB13.93x

EV/Sales

KYNB-5.61x

MCRB5.65x

EV/EBITDA

KYNB0.00x

MCRB0.00x

P/B Ratio

KYNB0.97x

MCRB0.85x

P/FCF Ratio

KYNBN/A

MCRBN/A

EV/FCF

KYNB0.68x

MCRB-0.21x

PEG Ratio

KYNBN/A

MCRBN/A

Forward P/E (NTM)

KYNBN/A

MCRBN/A

Forward P/S (NTM)

KYNB3.52x

MCRBN/A

Revenue (TTM)

KYNB$5M

MCRB$2M

Revenue Growth (YoY)

KYNB-91.4%

MCRBN/A

Forward Rev Growth

KYNB21.6%

MCRB-98.0%

Gross Margin (TTM)

KYNB6.3%

MCRB0.0%

Operating Margin (TTM)

KYNB0.0%

MCRB0.0%

EBITDA Margin (TTM)

KYNB-1083.7%

MCRB-3971.2%

Net Margin (TTM)

KYNB3967.8%

MCRB-1192.9%

FCF Margin (TTM)

KYNB-824.4%

MCRB-2724.1%

Net Income (TTM)

KYNB$183M

MCRB$-22M

FCF (TTM)

KYNB$-38M

MCRB$-51M

EPS (TTM)

KYNB$45.25

MCRB-$2.30

ROE (TTM)

KYNB-29091.0%

MCRB-6032.0%

ROA (TTM)

KYNB156.8%

MCRB-1794.0%

ROIC (TTM)

KYNB-25645.0%

MCRB-6032.0%

Cash

KYNB$51M

MCRB$16M

Debt

KYNB$0

MCRB$0

Net Cash/Debt

KYNB$51M

MCRB$16M

Current Ratio (TTM)

KYNB2.69x

MCRB2.11x

Quick Ratio (TTM)

KYNB2.57x

MCRB2.04x

Debt/Equity (TTM)

KYNB0.59x

MCRB0.00x

Debt/Assets (TTM)

KYNB0.0%

MCRB0.0%

Interest Coverage (TTM)

KYNBN/A

MCRBN/A

Net Debt/EBITDA (TTM)

KYNB0.00x

MCRB0.00x

Beta

KYNB1.07

MCRB0.49

52W Performance

KYNB-46.4%

MCRB-86.2%

YTD Performance

KYNB-33.3%

MCRB-82.1%

% from 52W High

KYNB-47.6%

MCRB-91.0%

% from 52W Low

KYNB8.7%

MCRB12.0%

Asset Turnover (TTM)

KYNB0.05x

MCRB0.02x

FCF Yield (TTM)

KYNB-153.8%

MCRB-195.5%

Earnings Yield (TTM)

KYNB740.3%

MCRB-85.6%

Dividend Yield (TTM)

KYNBN/A

MCRBN/A

Rule of 40

KYNB-915.8

MCRB-2,724.1

EV/GP/RG

KYNBN/A

MCRBN/A

Ticker research

View KYNB research View MCRB research

Metric	KYNB Kyntra Bio Inc	MCRB Seres Therapeutics Inc
Market & Valuation
Market Cap	$25M	$26M
Enterprise Value	$-26M	$11M
Price	$6.11	$2.71
P/E Ratio	0.14x	N/A
P/S Ratio	5.36x	13.93x
EV/Sales	-5.61x	5.65x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.97x	0.85x
P/FCF Ratio	N/A	N/A
EV/FCF	0.68x	-0.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.52x	N/A
Revenue & Growth
Revenue (TTM)	$5M	$2M
Revenue Growth (YoY)	-91.4%	N/A
Forward Rev Growth	21.6%	-98.0%
Profitability
Gross Margin (TTM)	6.3%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1083.7%	-3971.2%
Net Margin (TTM)	3967.8%	-1192.9%
FCF Margin (TTM)	-824.4%	-2724.1%
Net Income (TTM)	$183M	$-22M
FCF (TTM)	$-38M	$-51M
EPS (TTM)	$45.25	-$2.30
ROE (TTM)	-29091.0%	-6032.0%
ROA (TTM)	156.8%	-1794.0%
ROIC (TTM)	-25645.0%	-6032.0%
Financial Health
Cash	$51M	$16M
Debt	$0	$0
Net Cash/Debt	$51M	$16M
Current Ratio (TTM)	2.69x	2.11x
Quick Ratio (TTM)	2.57x	2.04x
Debt/Equity (TTM)	0.59x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.07	0.49
52W Performance	-46.4%	-86.2%
YTD Performance	-33.3%	-82.1%
% from 52W High	-47.6%	-91.0%
% from 52W Low	8.7%	12.0%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.02x
FCF Yield (TTM)	-153.8%	-195.5%
Earnings Yield (TTM)	740.3%	-85.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-915.8	-2,724.1
EV/GP/RG	N/A	N/A
Ticker research	View KYNB research	View MCRB research